Revolution Medicines Officer Anthony Mancini Reports Sale of Common Shares
Chief Global Commercialization Officer Anthony Mancini reported selling common shares worth $431,946.90.
Related stories
Trading halted in HG
CIRO said trading in HG was halted.
L impact | EQUITY | Oct 29, 2026, 07:42 PM UTC
APi Group Reports Third-Quarter Revenue of $2.55 Billion
APi Group said third-quarter 2026 revenue rose 22.5% year over year to $2.55 billion, net income increased 21.4% to $102 million, and diluted EPS gained 20% to $0.24. The company c
M impact | EQUITY | Oct 29, 2026, 07:41 PM UTC
Stagwell Reports Third-Quarter 2026 Revenue of $816.03 Million
Revenue rose 9.8% year over year to $816.03 million. Net revenue grew 8.1%, including 7.4% organic growth; net income and diluted EPS declined.
M impact | EQUITY | Oct 29, 2026, 07:41 PM UTC
Insperity Reports Third-Quarter Revenue of $1.65B, Net Loss of $1M
Third-quarter 2026 revenue rose 1.7% year over year. Net loss narrowed to $1M from $20M, and diluted loss per share improved to $0.02 from $0.53. Higher revenue per worksite employ
M impact | EQUITY | Oct 29, 2026, 07:41 PM UTC
AST SpaceMobile Shares Gain Up to 6% After FCC Advances Satellite Spectrum Proposal
AST SpaceMobile shares rose as much as 6% on Thursday after the FCC advanced a proposal to expand spectrum available for satellites to connect directly to ordinary phones.
M impact | EQUITY | Oct 29, 2026, 07:39 PM UTC
Amgen Announces Dividend of R$ 0.325209295 per Unit
Amgen announced a fourth-quarter 2026 dividend of R$ 0.325209295 per unit.
M impact | EQUITY | Oct 29, 2026, 07:35 PM UTC